Posts

UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials

UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials

"Certain demographic groups have been the recipients of more legal scrutiny related to substance use than the majority of the population,” says lead researcher Cody Wenthur.

Walled Garden: Fighting for Inclusivity and Accessibility in the Psychedelic Renaissance

As the new industry blooms, researchers and other professionals are fighting to break down barriers to participation, information, and psychedelics themselves.
3 Reasons Why Diversity, Equity and Inclusion Matter in the Psychedelic Industry

Why Diversity, Equity and Inclusion Are Vital to the Psychedelic Industry

Steven Huang, a consultant for leading psychedelic medicine company Numinus, explains why the industry should "harness the power of diversity."